HOME
ABOUT US
STRATEGY
TEAM
PORTFOLIO
4BATLE ICAV
NEWSROOM
CONTACT
More
4BIO Capital Portfolio Company Redpin Therapeutics to be Acquired by Kriya Therapeutics
Spark Therapeutics enters into definitive merger agreement with Roche
Takeda announces its intention to acquire TiGenix